Literature DB >> 18338146

[Suicidal behavior in dermatology].

W Harth1, A Hillert, B Hermes, K Seikowski, V Niemeier, R W Freudenmann.   

Abstract

Even in dermatology one can potentially encounter suicidal patients. A risk of suicide can be preexisting, appear as complication of skin disorders or be triggered by medications such as interferons. Patients at risk must be specifically asked about suicidal ideations and tendencies. Acute suicide risk requires immediate crisis intervention. In dermatology suicide risk has been described in severe acne conglobata (especially men) and metastatic melanoma. Patients with chronic or potentially fatal disease or severe pain may be suicidal. In addition patients with depression, alcohol dependency, substance abuse, schizophrenia or borderline personality disorder are at special risk. We review psychodermatological diseases with risk of suicide and point out treatment strategies. More attention should be focused on the early recognition of a possible risk of suicide in dermatology patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338146     DOI: 10.1007/s00105-008-1509-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

Review 1.  Acne, depression, and suicide.

Authors:  Peter R Hull; Carl D'Arcy
Journal:  Dermatol Clin       Date:  2005-10       Impact factor: 3.478

2.  Depressive symptoms associated with scleroderma.

Authors:  R P Roca; F M Wigley; B White
Journal:  Arthritis Rheum       Date:  1996-06

Review 3.  [Psychiatric side effects during adjuvant therapy with interferon-alphain patients with malignant melanoma. Clinical evaluation as well as diagnostic and therapeutic possibilities].

Authors:  M Schäfer; T Messer; U Wegner; M H Schmid-Wendtner; M Volkenandt
Journal:  Hautarzt       Date:  1999-09       Impact factor: 0.751

4.  [Depression and suicidal intentions as a side effect of high dosage interferon-alpha therapy--two cases].

Authors:  D Windemuth; M Bacharach-Buhles; K Hoffmann; P Altmeyer
Journal:  Hautarzt       Date:  1999-04       Impact factor: 0.751

Review 5.  [Delusions of parasitosis: An up-to-date review].

Authors:  R W Freudenmann
Journal:  Fortschr Neurol Psychiatr       Date:  2002-10       Impact factor: 0.752

Review 6.  Antipsychotic treatment of primary delusional parasitosis: systematic review.

Authors:  Peter Lepping; Ian Russell; Roland W Freudenmann
Journal:  Br J Psychiatry       Date:  2007-09       Impact factor: 9.319

7.  Mental illness and suicide. A case-control study in east Taiwan.

Authors:  A T Cheng
Journal:  Arch Gen Psychiatry       Date:  1995-07

Review 8.  Delusional parasitosis: a new pathway for diagnosis and treatment.

Authors:  P Lepping; R W Freudenmann
Journal:  Clin Exp Dermatol       Date:  2008-01-16       Impact factor: 3.470

9.  Prevalence and correlates of suicidal ideation among patients with skin disease.

Authors:  Angelo Picardi; Eva Mazzotti; Paolo Pasquini
Journal:  J Am Acad Dermatol       Date:  2006-01-18       Impact factor: 11.527

10.  Suicidality in body dysmorphic disorder: a prospective study.

Authors:  Katharine A Phillips; William Menard
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more
  1 in total

1.  [Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis].

Authors:  J Dieris-Hirche; U Gieler; J P Kupfer; W E Milch
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.